respiratory tract infections

Respiratory tract infections (RTI) are infections of the airways like trachea and alveolar sacs, which are mainly caused by a broad spectrum of pathogenic microbes such as bacterias, viruses, and fungi. These are generally contagious acute infections transmitted between people through tiny droplets arising out during coughing and sneezing, direct or indirect contact with the contaminated surface. Central BioHub provides researchers worldwide with high-quality human biospecimens of patients diagnosed with respiratory tract infections. Search samples from our catalogue below or explore our advanced search options to order respiratory infection samples by clicking CLINICAL DIAGNOSIS, ICD-10-CM CODES, and LABORATORY PARAMETERS.

Show rows
|< < of > >|

Types of Respiratory Tract Infection:

Based on the infection location, respiratory tract infections are broadly divided into upper respiratory tract infections (URTIs) and Lower respiratory tract infections (LRTIs). Common cold, Acute Rhinosinusitis, Otitis media, Pharyngitis are upper respiratory tract infections characterized by mild to moderate symptoms that will cure without further ado. Contrary, lower respiratory tract infections including Pneumonia, Influenza, Bronchitis, and Bronchiolitis exhibit mild to severe symptoms that can be fatal if not treated immediately.

Need for Extensive Research:

Timely diagnosis and initiation of appropriate antimicrobial therapy are warranted for abating respiratory infections and slowing down disease progression. Growing antibiotic resistance is a matter of global concern as well as the recent outbreak of global spreading diseases like COVID-19. Today, respiratory pathogens are constantly gaining resistance to existing antibiotics and became a great challenge for physicians to tackle the infections. As a result, fostering novel antimicrobial research is critical for mitigating current conditions and preventing possible infections in future. According to the estimates, RTIs result in around 180 million antibiotic prescriptions per year in the EU-27 member countries, and 7 million antibiotic prescriptions were written for acute bronchitis and cough in individuals aged between 16 to 64 in the United States in 2003.
Respiratory tract infections, especially LRTI, are linked to a high rate of morbidity in the community and a high rate of mortality in hospitalized patients. Therefore, such diseases place a massive economic burden on both the health care system and patients.

Order RespiratoryTract Infection Biospecimens:

Central BioHub, a group of motivated scientists, proposes an ultimate solution for optimizing your human biospecimens procurement. Therefore, dedicating ourselves to bringing up superior quality Respiratory patient samples, Central BioHub connects certified global biospecimen suppliers to life science researchers. Our innovative online marketplace offers a wide range of respiratory infection biosamples that are carefully collected from ethically consented donors and stored at  certified biobanks and biorepositories. You can find respiratory infection biospecimens of patients at every age, gender, and ethnicity. The samples we provide includes human biosamples of pneumonia, influenza or flu, covid, bronchitis, tuberculosis etc. 
With complete assistance from our scientific team, global life science scientists can purchase Infectious disease samples through the safest, open-access, fast virtual interface of Central BioHub. Every respiratory infection biosamples such as human serum, plasma, whole blood and respiratory secretions are well preserved and devoid of cross-contamination to optimize research output accuracy. Striving for excellence, we leverage to ensure safe and fast international shipping of Respiratory biological specimens  and other research samples. Connect us to purchase the most credible, high-quality, and premium human biospecimens of respiratory tract infections online.